Lifeboat Foundation

Main episode with Tom Campbell (Dec 2020): https://youtu.be/kko-hVA-8IU?list=PLZ7ikzmc6zlN6E8KrxcYCWQIHg2tfkqvR Listen on Spotify: https://open.spotify.com/show/4gL14b92xAErofYQA7bU4e

Nuclear power already has an energy density advantage over other sources of thermal electricity generation. But what if nuclear generation didn’t require a steam turbine? What if the radiation from a reactor was less a problem to be managed and more a source of energy? And what if an energy conversion technology could scale to fit nuclear power systems ranging from miniature batteries to the grid? The Defense Advanced Research Projects Agency (DARPA) Defense Sciences Office (DSO) is asking these types of questions in a request for information on High Power Direct Energy Conversion from Nuclear Power Systems, released August 1.

which is widely believed to be the root cause of many age-related diseases.

The study, published today in the journal npj Aging, raises the exciting possibility of a protective agent that could dampen age-related inflammation and restore normal immune function in older adults.

PEPITEM (Peptide Inhibitor of Trans-Endothelial Migration) was initially identified at the University of Birmingham in 2015. While the role of the PEPITEM pathway has already been demonstrated in immune-mediated diseases, this is the first data showing that PEPITEM has the potential to increase healthspan in an aging population.

Non-personalized content and ads are influenced by things like the content you’re currently viewing and your location (ad serving is based on general location). Personalized content and ads can also include things like video recommendations, a customized YouTube homepage, and tailored ads based on past activity, like the videos you watch and the things you search for on YouTube. We also use cookies and data to tailor the experience to be age-appropriate, if relevant.

Select “More options” to see additional information, including details about managing your privacy settings. You can also visit g.co/privacytools at any time.

We’re closer to a cure for HIV than ever before. This half hour, Scripps News examines the fight against a virus that has killed millions of people around the world in the last generation.

In 2023 there were nearly 40 million people living with HIV. Some 30.7 million of them receive antiretroviral treatment. Despite recent advances in preventing infections, more than a million people are expected to become newly infected in 2024. More than 600,000 will die of HIV/AIDS.

But a handful of people have now been cured, thanks to recent breakthroughs in treatment.

SpaceX is working towards the goal of landing both the super heavy booster and Starship on a drone ship in the ocean, which has the potential to revolutionize space travel and support their mission for greater sustainability and reusability Questions to inspire discussion What is SpaceX’s goal for landing the super heavy booster and Starship?

‘Earth Science to Action: How NASA connects space to village’ Learn from experts how NASA’s cutting-edge Earth observation and satellite technology is empowering communities worldwide to tackle climate change and natural disasters. This talk, organised by the SERVIR-HKH initiative at ICIMOD, features key speakers Dan Irwin (SERVIR Global Program Manager) and Ashutosh Limaye (SERVIR Chief Scientist) from NASA Marshall Space Flight Center. Learn how these advancements are bridging the gap between data and actionable insights for a thriving planet.

Creative Diagnostics provides expertise in antiviral (or antibacterial) assays, cell-based antiviral (or antibacterial) compound screening, and best in vivo model solutions to drive your projects to completion. We are a reliable partner for biotechnology and pharmaceutical companies.

PLATO, or PLAnetary Transits and Oscillations of stars, is being built to find nearby potentially habitable worlds around Sun-like stars that we can examine in detail.

The space telescope will blast into orbit on Europe’s new rocket, Ariane-6, which made its maiden flight last week after being developed at a cost of €4billion (£3.4billion).

Dr David Brown, of the University of Warwick, is giving an update on the mission at the Royal Astronomical Society’s National Astronomy Meeting at the University of Hull this week.